Carevive’s Director of Research, Debra Wujcik, PhD, RN, FAAN, will be presenting two posters at the 2019 MASCC/ISOO Annual Meeting in San Francisco on June 21-23. The posters explore the usage of Carevie’s patient-reported outcomes (PROs) tools to assess cancer pain associated with severe flares and end-of-dose failure and how chronic lymphocytic leukemia (CLL) patients can benefit from the collection of their PROs and use of a geriatric assessment (GA).
The MASCC/ISOO Annual Meeting is the foremost international and multidisciplinary conference on supportive care. It covers the entire spectrum of problems experienced by patients as a result of their cancer, as well as their cancer treatment. The main themes of this year’s Annual Meeting are “Digital Health”, “New Treatments, New Toxicities”, “Sexual Health”, and “Cancer Survivorship” and Carevive is excited to be attending and presenting since those topics are very much aligned with our vision to provide oncology digital tools to support cancer care management and patient engagement.
The Multinational Association of Supportive Care in Cancer (MASCC) is a multidisciplinary organization dedicated to research and education of supportive care professionals worldwide. The mission of MASCC is to improve the supportive care of people with cancer, from diagnosis, through treatment and survival, to end of life. Founded in 1990, MASCC now includes members from more than 70 countries and 6 continents.
Over the years, the International Society of Oral Oncology (ISOO) has attracted a significant number of new members. Established in 1984 as The Society for Clinical and Experimental Oral Oncology, ISOO has played a pivotal role as the sole international platform for healthcare professionals interested in multidisciplinary approaches to oral supportive care for cancer patients. An alliance with MASCC was established in 1998 and continues to this day. This collaboration has provided a professional and scientific milieu in which to promote scientific exchange among different healthcare professionals concerned about the impact of cancer treatment on the oral environment, including its effects on tissues, health, and function.
This year’s conference will have several joint sessions with partner organizations (e.g. EONS, ISNCC, ONS, SIOG), and the usual mix of plenary sessions, parallel sessions, and workshops. The faculty is international and features leading experts in all areas of supportive care (and beyond), including Ethan Basch, Director of Carevive’s Scientific Advisory Board.
Meet Carevive at #MASCC19
Heading to this year’s conference? Send us an email and let’s start a conversation!
POSTER PRESENTATION SCHEDULE
June 22. Session 14: Digital Health. 13:50 – 15:20
Technology Supported Patient Reported Outcome Assessment in the Clinic and from Home in Patients with Chronic
June 22. Session 18: Cancer Pain. 15:50-17:20
Tablet Based Expanded Pain Assessment Reveals Severe Flares and End of Dose Pain at Home